Figure 6: LysGH15 did not cause significant adverse effects.

The mice were immunized with LysGH15 at 3 weeks prior to the intravenous administration of large amounts of LysGH15 or buffer. The mice were monitored for 10 days and euthanized on day 11. (A) The health score was assessed as described in the Methods section. (B) Pathological changes and histopathology of the organs. The hearts, livers, spleens, lungs, kidneys, and colons were stained with haematoxylin and eosin. n = 6 mice per group per experiment. *P < 0.05 compared to the buffer-treated control; N.S. not significant. The data are representative of three experiments.